Document Detail

Carbamylated hemoglobin in prerenal azotemia.
MedLine Citation:
PMID:  8569946     Owner:  NLM     Status:  MEDLINE    
CONCLUSION: Carb Hb may be elevated after a minimum of 4 days' transient BUN elevation; Carb Hb is not useful in differentiating between mild acute renal failure and prerenal azotemia.
J M Frazao; R H Barth; G M Berlyne
Related Documents :
3995036 - Effects of preparative procedures on the volume and content of resealed red cell ghosts.
8569946 - Carbamylated hemoglobin in prerenal azotemia.
2251966 - Thiamine status of healthy and institutionalized elderly subjects: analysis of dietary ...
9708696 - The 2,3-dpg levels of human red blood cells during an incremental exercise test: relati...
2865246 - Role of beta-adrenergic mechanisms during exercise in poorly controlled diabetes.
3618486 - Comparison of nifedipine and isosorbide dinitrate when added to maximal propranolol the...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Nephron     Volume:  71     ISSN:  0028-2766     ISO Abbreviation:  Nephron     Publication Date:  1995  
Date Detail:
Created Date:  1996-03-05     Completed Date:  1996-03-05     Revised Date:  2014-07-29    
Medline Journal Info:
Nlm Unique ID:  0331777     Medline TA:  Nephron     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  153-5     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Blood Urea Nitrogen
Carbamates / blood*
Creatinine / blood
Diagnosis, Differential
Hemoglobins / metabolism*
Kidney Diseases / blood*
Middle Aged
Renal Insufficiency / diagnosis
Time Factors
Uremia / blood*,  diagnosis
Valine / metabolism
Reg. No./Substance:
0/Carbamates; 0/Hemoglobins; AYI8EX34EU/Creatinine; HG18B9YRS7/Valine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pharmacokinetic study of the low-molecular-weight heparin fraxiparin in patients with nephrotic synd...
Next Document:  Interferon treatment of chronic active hepatitis C in patients with end-stage chronic renal failure.